The competition between the US Optical Genome Mapping Market and the China Optical Genome Mapping Market is hitting record highs this year. In the US, the focus is on clinical integration, with major cancer centers using OGM to replace outdated karyotyping. It is a para without source unique content 20 doc evolution that is making cancer diagnostics faster and much more...